Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.39 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.31 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27958932 | 0.97 | DNM1 (0.39) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL14958464 | 0.85 | TSHR (0.32) | HTTHSP90AA1TSHRPSMD14PLA2G1B | |
| SCHEMBL28230537 | 0.83 | TSHR (0.40) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Hydrochloric Acid SCHEMBL14957656 | 0.82 | CYP3A4 (0.32) | TSHR | |
| Hydrochloric Acid SCHEMBL27958899 | 0.81 | BBOX1 (0.37) | RAD52BBOX1TSHRPSMD14PLA2G1B | |
| Water SCHEMBL3302970 | 0.81 | DNM1 (0.39) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| SCHEMBL4230927 | 0.81 | DNM1 (0.44) | DNM1HTTHSP90AA1RAD52TSHR | |
| Hydrochloric Acid SCHEMBL28151661 | 0.79 | DNM1 (0.42) | DNM1HTTHSP90AA1RAD52TSHR | |
| SCHEMBL4236054 | 0.77 | DNM1 (0.54) | DNM1HTTKMT2AHSP90AA1RAD52 | |
| Hydrochloric Acid SCHEMBL8859622 | 0.77 | DNM1 (0.36) | DNM1HTTKMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7595411-B2 | Phospholipid-analogous compounds | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2009-09-29 | — | — | US | disclosed |
| US-20050165245-A1 | Phospholipid-analogous compounds | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2005-07-28 | — | — | US | disclosed |
| US-6344576-B1 | CATIONIC PHOSPHATIDES AND GLYCERIDES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-02-05 | — | — | US | disclosed |
| EP-1102775-A1 | NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2001-05-30 | — | — | EP | disclosed |
| EP-1019417-A1 | PHOSPHOLIPID ANALOGUE COMPOUNDS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2000-07-19 | — | — | EP | disclosed |
| WO-2000008031-A1 | NOVEL PHOSPHOLIPIDS WITH UNSATURATED ALKYL AND ACYL CHAINS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2000-02-17 | — | — | WO | disclosed |
| WO-1999009037-A1 | PHOSPHOLIPID ANALOGUE COMPOUNDS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1999-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165245-A1 | Phospholipid-analogous compounds | PHOSPHO1, SGMS1, SGMS2 | DNM1 1381/4885HTT 3569/4885KMT2A 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.